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Abstract
Background: Canine breeds may be considered good animal models for the study of genetic predisposition to
cancer, as they represent genetic clusters. From epidemiologic and case collection studies it emerges that some
breeds are more likely to develop lymphoma or specific subtypes of lymphoma but available data are variable and
geographically inconsistent. This study was born in the context of the European Canine Lymphoma Network with
the aim of investigating the breed prevalence of canine lymphoma in different European countries and of
investigating possible breed risk of lymphoma overall and/or different lymphoma subtypes.
Results: A total of 1529 canine nodal lymphoma cases and 55,529 control cases from 8 European countries/institutions
were retrospectively collected. Odds ratios for lymphoma varied among different countries but Doberman, Rottweiler,
boxer and Bernese mountain dogs showed a significant predisposition to lymphoma. In particular, boxers tended to
develop T-cell lymphomas (either high- or low-grade) while Rottweilers had a high prevalence of B-cell lymphomas.
Labradors were not predisposed to lymphoma overall but tended to develop mainly high-grade T-cell lymphomas. In
contrast with previous studies outside of Europe, the European golden retriever population did not show any possible
predisposition to lymphoma overall or to specific subtypes such as T-zone lymphoma.
Conclusion: Further prospective studies with more precise and consistent subtype identification are needed to
confirm our retrospective results and to create the basis for the investigation of possible genes involved in different
predispositions.
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Background
The study of cancer epidemiology in canine populations
has earned a focus of attention, because tumour bearing
dogs may help in better understanding a broad spectrum
of determinants that may contribute to cancer develop-
ment. In contrast to human populations, canine breeds
can be considered as genetic clusters. Hence, they may
provide genetic population information for studies on
incompletely understood genetic disease predisposition
[1, 2]. In addition, the great similarities of the disease
complex, similar incidence and shared risk factors fur-
ther support the use of canine lymphoma as a model for
the human counterparts. To date, few specific studies on
the epidemiology of canine lymphoma compared to the
whole canine population have been published [3–11]
(Additional file 1: Table S1).
Further data on the prevalence of specific lymphoma
subtypes among different breeds can be found in larger
lymphoma studies [12–25] (Additional file 2: Table S2).
From these data taken together, it emerges that lymphoma
is over-represented in the Doberman, Bernese mountain
dog, Rottweiler, boxer, and bullmastiff breeds, independently
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of geographic origin. However, for other breeds, and
particularly for the golden retriever, the high prevalence
of lymphoma is found solely outwith Europe. Specific
studies comparing European (EU) and extra-EU case-
loads are currently lacking.
In addition to lymphoma in general, differing predisposi-
tions to lymphoma subtypes and immunophenotypes have
been identified among canine breeds [25]. Interestingly, a
high prevalence of golden retriever was documented in
non-EU dogs with T-zone lymphoma [13, 17, 21, 24] but
EU studies have not reached the same conclusion [7, 15].
When all data are analysed together, the risk of lymph-
oma overall and the distribution of specific lymphoma
subtypes varies among different countries with golden
retrievers experiencing even greater inconsistencies in
distribution than other breeds.
The present retrospective study was designed in the
context of the European Canine Lymphoma Network, a
community of researchers working on lymphoma diag-
nosis and cure, which now incorporates more than 80
researchers from throughout Europe. Our aim was to
investigate the breed prevalence in lymphoma in clinical
caseloads from multiple European institutions. Data
were compared to adequate control groups to define the
overall breed risk of lymphoma in general, or in a spe-
cific lymphoma subtype.
Methods
Inclusion criteria
Databases of 8 different institutions based in different
European countries (Austria, France, Italy, Netherlands,
Portugal, Spain, Switzerland and United Kingdom) were
retrospectively searched for consecutive cases of canine
nodal lymphoma within a six year timeframe (2010–2015).
Institutions enrolled were all referral centers for veterinary
oncology, all located in academia, except one private refer-
ral center. Criteria for inclusion included a final diagnosis
of lymphoma, based on results of clinical and laboratory
data (variably including cytology, immunophenotyping or
histopathology, depending on institution) and the availabil-
ity of signalment data. As a control, the same institution
provided a list of consecutive canine cases, from the same
hospital databases with a diagnosis other than lymphoma,
in the same timeframe. These control groups were used to
compare the prevalence for each breed in the lymphoma
group, in order to correct for other possible sources of
variation, such as high breed popularity in one area. The
number of control cases varied among institutions but in
all cases they exceeded the number of lymphoma cases
(generally at least 10 fold higher). Data from dogs with
lymphoma were analysed after matching with the appropri-
ate control from the same geographic area in order to
correct results for the breed prevalence among the whole
canine population.
When immunophenotype and lymphoma subtype were
available these data were also recorded. Since diagnostic al-
gorithms and classification schemes differ greatly among
institutions, the subtypes recognized were grouped into 3
main groups: 1) B-cell lymphoma (all subtypes), 2) T-cell
lymphoma-high grade, 3) T-zone lymphoma/T indolent
lymphoma (identification based on histopathology, cytology
or immunophenotyping).
Statistical analysis
The 9 most represented breeds in the whole lymphoma
database were considered for statistical purposes. The
prevalence of different breeds in the databases from dif-
ferent countries varied but these 9 selected breeds were
always among the 12 most common breeds for each
country included in the study. We limited the analysis to
these breeds in order to make comparisons between
different institutions consistent.
Using country-matched control groups obtained from
internal databases of each institution, odds ratio (OR)
analysis was performed to quantify the association, if
any, between lymphoma predisposition and breed within
each country. ORs were expressed with relative 95% confi-
dence interval.
The differences between control and lymphoma groups
were evaluated using Chi-square test.
A breed was considered predisposed if p < 0.05 and
OR > 1.0. When OR > 3.0 (corresponding to a moderate
positive risk) a breed was defined as highly predisposed,
as used previously in Ernst et al. [5].
Multinomial logistic regression was used to define the
predisposition to a specific lymphoma subtype in the 9
chosen breeds (in comparison with the crossbred popu-
lation), with lymphoma subtype the response variable
and breed the explanatory variable. B-cell lymphoma
was considered as reference of the response variable;
therefore, two models were constructed for each breed: a
model comparing high-grade T-cell to B-cell lymphoma
and a model comparing T-zone to B-cell lymphoma.
Results are reported as odds ratios (OR) with the associ-
ated 95% confidence intervals (CI).
Statistical analysis was performed using PROC LOGISTIC
(SAS 9.4, SAS Inst. Inc., Cary, NC).
Ethics
The University of Liverpool ethics committee approved
the study (number VREC442). According to national
regulations and to the Animal Experimentation Ordinance
of the “Comitato Etico Scientifico per la Sperimentazione
Animale” of the University of Milan (EC decision 29
October 2012, renewed with the protocol n° 02–2016), the
other institutions involved in this international research
project did not require further permissions to proceed
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with this retrospective study, as data had already been ac-
quired during normal clinical activity.
Results
A total of 1529 canine lymphoma cases and 55,529 control
cases were collected among all institutions.
The following 9 breeds were over-represented among
lymphoma-affected dogs: Labrador retriever (n = 91, 5.5%),
boxer (n = 88; 5.1%), German shepherd (n = 72; 4.2%),
golden retriever (n = 71; 4.1%), Rottweiler (n = 62; 3,6%),
Bernese mountain dog (n = 60; 3.5%), Doberman (n = 35;
2.0%), English cocker spaniel (n = 33; 1.9%) and beagle
(n = 28; 1.6%).
Prevalence varies among different countries, partly
reflecting the prevalence of the breeds in their local ca-
nine population. OR for lymphoma were calculated for
each breed in single countries and are shown in Fig. 1
and Table 1. Briefly, Rottweilers and Dobermans showed
a statistical predisposition to develop lymphoma (OR > 3)
in 5 out of 8 countries, Bernese mountain dog in 4 out
of 8; while German shepherd and Labrador retriever
were found to be predisposed just in Switzerland and
boxer just in France. Golden retrievers were found to be
mildly predisposed just in the UK (OR = 2.16; confidence
limit = 1.34–3.49) while no predisposition was recorded in
other countries.
For analysis of lymphoma subtypes, all countries were
grouped together as the number of cases having a
lymphoma subtype classification was too low to perform
analysis by countries. Immunophenotype and cyto-histotype
data were available in 1446 dogs and were used to categorize
cases into the above mentioned main groups: B-cell
lymphoma (n = 950; 65,7%), T-cell lymphoma-high
grade (n = 396; 27,4%), and T-zone lymphoma/T indolent
lymphoma (n = 100; 6,9%). No statistical differences were
found in the prevalence of lymphoma subtypes between
Fig. 1 Odds Ratio (OR) and confidence interval to develop lymphoma for each canine breed in each country. P values are expressed for OR > 3
suggesting a high predisposition. LAR = Labrador Retriever, GSH = German Shepherd; GR = Golden Retriever; BOX = Boxer; BMD = Bernese Mountain
Dog; ROT = Rottweiler; DOB = Doberman; BEA = Beagle; ECS = English Cocker Spaniel; ns = not significant;*p < 0.05; **p < 0.01; ***p < 0.001
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the whole canine population and crossbreeds. Results of
the prevalence of lymphoma subtypes compared with
crossbreeds used as controls are shown in Table 2.
From our results, it emerges that boxer and Labrador re-
triever were predisposed to develop high-grade T-cell lymph-
omas (respectively 10.9 fold and 2.7 fold compared with
crossbreeds) while the Rottweiler was highly predisposed to
have B-cell lymphoma (8.1 fold more likely than high-grade
T-cell lymphoma). Boxers also showed a predisposition to
T-zone lymphoma in comparison with B-cell lymphoma but
no difference was found when compared with high-grade
T-cell lymphoma. Interestingly, no predisposition to T-zone
lymphomas was found in golden retriever in comparison to
either B-cell lymphomas or high-grade T-cell lymphomas.
Discussion
Reported canine breed predispositions to lymphoma and dif-
ferent lymphoma subtypes are scarce and often inconsistent
among studies. Dog breeds, as genetic clusters, represent an
excellent model to study genetic predisposition to oncogen-
esis. In our study, the breed prevalence of lymphoma was
investigated in clinical caseloads from 8 European countries/
institutions, and was compared to adequate control groups
in order to define breed risks of developing lymphoma over-
all and of developing different lymphoma subtypes. In order
to quantify our findings and minimize possible biases due to
control group or any statistical artifacts, we arbitrarily defined
a breed as highly predisposed when OR was higher than 3
(moderate to high risk).
Results from the present study confirm the prior
suggested predisposition of Bernese mountain dogs,
Rottweilers, and Dobermans of developing lymphoma.
These results are in agreement with previous findings of
breed predispositions both in- and outside Europe [3, 8].
Other breeds showed a wider variation among differ-
ent countries.
Table 1 Odds Ratio (OR) values for lymphoma that results significant to statistical analysis
Portugal Italy United Kingdom Spain Austria Switzerland France Netherlands
OR OR OR OR OR OR OR OR
Labrador Retriever ns ns ns ns ns 3.33** 2.05* ns
German Shepherd ns ns ns ns ns 3.27** ns 2.9*
Golden Retriever ns ns 2.16* ns ns ns ns ns
Boxer ns 2.92*** 2.56*** ns ns ns 6.89** ns
Bernese ns 2.6* 3.25* ns 10.18*** 5.26*** 14.39*** 2.92**
Rottweiler 4.59*** 2.29* ns 3.06* 5.78*** ns 9.39*** 4.99***
Doberman 8.84*** 5.89*** ns 6.05* ns 7.66*** 12.15** ns
Beagle ns ns ns ns ns ns ns ns
English Cocker Spaniel ns ns ns ns ns ns ns ns
OR Values higher that 3 are in bold
ns not significant
*p < 0.05; **p < 0.01; ***p < 0.001
Table 2 different lymphoma subtypes no (percentage in brackets) in different breeds and Odds Ratio (OR) values (with confidence interval)
in comparison with crossbreeds (XXX)
B-cell lymphoma HG T-cell lymphoma T-zone lymphoma TOT
OR vs XXX OR vs XXX OR vs XXX
Labrador Retriever 44 (53.0%) ref 35 (42.2%) 2.74 (1.61–4.67) 4 (4.8%) 1.40 (0.44–4.49) 83
German Shepherd 52 (80%) ref 11 (16.9) 0.73 (0.36–1.49) 2 (3.1) 0.59 (0.13–2.70) 65
Golden Retriever 48 (71.6%) ref 16 (23.9) 1.15 (0.61–2.17) 3 (4.5%) 0.96 (0.26–3.51) 67
Boxer 12 (21.4%) ref 38 (67.9%) 10.9 (5.36–22.3) 6 (10.7%) 7.69 (2.49–23.8) 56
Bernese Mountain Dog 41 (78.9%) ref 10 (19.2%) 0.84 (0.40–1.78) 1 (1.9%) 0.38 (0.05–2.95) 52
Rottweiler 56 (94.9%) ref 2 (3.4%) 0.12 (0.03–0.52) 1 (1.7%) 0.28 (0.03–2.15) 59
Dobermann 30 (85.7%) ref 4 (11.4%) 0.46 (0.16–1.36) 1 (2.9%) 0.51 (0.07–4.06) 35
Beagle 18 (66.7%) ref 7 (25.9%) 1.34 (0.53–3.37) 2 (7.4%) 1.71 (0.36–8.18) 27
English Cocker Spaniel 18 (60%) ref 11 (36.7%) 2.11 (0.94–4.71) 1 (3.3) 0.86 (0–11-6.91) 30
Crossbreeds 200 (73.8%) – 58 (21.4%) – 13 (4.8%) – 271
Significant data are in bold
Ref Reference value
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Boxers were found to be highly predisposed only in
France (OR = 6.89) although a mild to moderate statis-
tical predisposition (OR lower than the value of 3) was
also found in Italy (OR = 2.92) and the UK (OR = 2.56).
In addition, this result supports a previous report from
France [7], in which Boxers were the only breed found
to be predisposed to lymphoma in that country. The
same predisposition was confirmed in other published
studies from Australia [3], USA [8] and UK [9] . In sum-
mary, boxers could be considered as a breed at-risk of
developing lymphoma in Europe.
Conflicting results arise from analysis of the golden re-
triever population, which only showed a modest predis-
position for developing lymphoma in the UK (OR < 3).
Golden retrievers have however been reported to be highly
predisposed to lymphoma development in a study from
the USA [8]. This breed was generally over-represented in
American and Japanese canine lymphoma case series, often
constituting more than 20% of cases [13, 17, 21, 24] . Re-
cently, geographic variation between different regions of
the USA in the prevalence of T-zone lymphoma in Ameri-
can golden retriever has been reported [12]. This regions
varying prevalence among lymphoma subtypes was sug-
gested to be a possible consequence of environmental risk
factors, as already demonstrated in humans [26].
Environmental risk factors may explain the different
breed risks observed between American and European
studies, but also possible is differing genetic predispos-
ition to lymphoma between American and European
golden retrievers breed lineages. The two breed lineages
are particularly different in terms of morphotype, with
minimal interbreeding. Existing genetic differentiation
between “American” and “European-British” golden re-
trievers have been detected in research on mast cell
tumors [27]. Although we consider risk factors as an im-
portant source of bias in our cases, we think the genetic
explanation as more likely, as no differences were ob-
served in term of predisposition to lymphoma in general
and/or T-zone lymphoma between European countries
(regardless of non-homogeneous distribution of possible
risk factors). Assessing the role of environmental risk
factors was beyond the scope of the present study, but
we expect they might influence the percentage of
lymphoma cases in a certain area irrespective of breed.
In contrast, we found no difference in the prevalence of
lymphoma in the whole canine population or in mixed
breeds among European and American lymphoma case
series. The effects and interaction between environmental
risk factors and breed-related predisposition would be bet-
ter investigated in a prospective study collecting informa-
tion related to environment, exposure to pollutants and
owners’ habits.
Breed prevalence of T- vs B-cell lymphoma has been
evaluated by several authors. Modiano et al. [25] found a
higher prevalence of T-cell lymphoma in boxers and
golden retriever; and B-cell lymphoma in Dobermans in
comparison with crossbreed dogs. More recently a pre-
dilection for T-cell lymphoma in boxers was demon-
strated in a Polish study [6]; this was also confirmed by
Lurie et al. [28], with a predilection for the T lymphoblastic
subtype (high-grade T-cell lymphoma) in boxer dogs. Un-
fortunately, the Polish study did not differentiate between
high- and low-grade T- cell lymphoma, a distinction that is
important not only in terms of prognosis and clinical ap-
proach but also in terms of possible genetic predisposition.
In our study, we aimed to differentiate the lymphoma
subtypes in the investigated population, when possible.
However, since classification schemes, diagnostic pathways
and nomenclature varied markedly between institutions,
we elected to separate the lymphoma cases in 3 different
classes: B-cell lymphoma, high-grade T-cell lymphoma,
and low-grade T-cell/T-zone lymphoma. These divisions
allowed collection of an adequate number of cases in each
class, with separation of the differing prognoses between
classes. We decided not to separate high-grade and
low-grade B cell lymphomas due to: 1) the high prevalence
of high-grade lymphoma vs low-grade in dogs; 2) the
difficulty in defining the grade in some B-cell lymph-
oma subtypes (such as marginal lymphoma, late stage);
3) the paucity of studies on different outcome in nodal
high vs low-grade B-cell lymphomas. Indeed, a median
lymphoma-specific survival of 13 months was found in
marginal zone lymphoma (the most diffuse low-grade
B-cell lymphoma), which did not differ from survival
reported in high-grade B-cell lymphoma [21].
Our results confirm the already reported predispos-
ition of boxers for T-cell lymphoma in general but they
also underline the possible predispositions of Labrador
retriever to high-grade T-cell lymphoma and of Rottweilers
to B-cell lymphomas, which have not previously been de-
scribed. The absence of a more precise classification of
lymphoma subtype (Peripheral T Cell vs lymphoblastic for
T cell lymphomas, Diffuse Large B Cell vs marginal vs fol-
licular for B cell lymphomas) does not permit further con-
clusion to be drawn on these possible predispositions, but
opens the door to more specific studies with a consistent
classification. One of the most exciting results of our find-
ings is that in Europe golden retrievers do not have a
higher probability of developing T-zone lymphoma, either
compared to B-cell lymphoma or high-grade T-cell lymph-
oma in its own right. This finding differs from the majority
of studies published in the USA and Japan and opens new
perspectives on different genetic predispositions to lym-
phomagenesis, considering that golden retriever popula-
tions differ in terms of morphology and share minimal
interbreeding. Confirmation of our results with a prospect-
ive study using a standardized classification method would
be useful to clarify this finding, before focusing on
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identification of genetic regions involved in the different
predispositions.
Limitations of the present study should be considered
and are mainly secondary to its retrospective nature.
Firstly, a common standard classification for all cases
was not available, since classification schemes (WHO vs
updated Kiel classification), diagnostic algorithms and
techniques used varied among different institutions. In
order to provide consistency between data, collected
cases were categorized where possible into three cat-
egories (B cell lymphoma, irrespective from the grade;
high-grade T cell lymphoma and T zone lymphoma).
Although incomplete, this categorization allowed to
provide more information than the simple diagnosis
of lymphoma and to include the majority of cases.
However, in many cases, subtype identification was
not provided or it was based just on an incomplete
panel of tests (e.g. cytology alone). These cases could
not be subdivided into the three categories and were
excluded from statistical analysis on subtypes. The
lack of a common classification in different subtypes
could affect the meaning of our results regarding pos-
sible breed predispositions to B cell lymphomas and
T high grade lymphomas. However, it could be consid-
ered more valid for T zone lymphomas, as they represent
a more homogenous lymphoma subtype with well- recog-
nized biological behaviour. More specific studies could be
performed by using a standard diagnostic approach (in-
cluding cytology, histopathology, and immunophenotyp-
ing in all cases) and a common unique classification
scheme in order to confirm the data derived from this
retrospective analysis and to better identify breed-specific
predilections that could be then used for possible genetic
studies.
The second limit is due to the choice of control cases.
Non-lymphoma cases were selected from the same data-
base used for the extraction of lymphoma cases, in order
to correct results for the breed distribution, which is
highly variable among countries. These databases in-
cluded diseased dogs presented at clinical examination
or tissue samples sent for laboratory tests (cytology, flow
cytometry). The breed prevalence in these databases is
not necessarily representative of the whole canine popu-
lation in each country. However, we considered it the
most reliable control group available, since breed data
on overall canine populations were not available for all
countries, and are not consistent between European
countries and areas. Bias could occur as all the institutions
derive their database solely from diseased animals, and
breed distribution may vary according to different breed
predisposition to other diseases. However, due to the high
number of control cases and the variety of possible
diseases included, we considered this as a minor bias for
the breed analyzed.
Conclusions
The results of the present study confirm that in spite of
some differences among countries, some dog breeds are
predisposed to developing lymphoma in general and
some predisposed to specific canine lymphoma subtypes.
This is particularly true for the Rottweiler, suffering a
higher prevalence of B-cell lymphoma and the boxer,
with a higher prevalence of T-cell lymphoma (either
high-grade or T-zone lymphoma). Other breeds such as
the Doberman and Bernese Mountain dog are highly
predisposed to the development of lymphoma in general
with no specific subtype predisposition. In contrast, the
golden retriever, previously reported as predisposed to the
development of lymphoma and particularly to T-zone
lymphoma in the USA, did not show any particular predis-
position in the herein investigated European case series.
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